Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

J.J.C. Verhoeff; C. Lavini; M.E. van Linde; L.J.A. Stalpers; C.B.L.M. Majoie; J.C. Reijneveld; W.R. van Furth; D.J. Richel

doi:10.1093/annonc/mdp591

Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

J.J.C. Verhoeff, C. Lavini, M.E. van Linde, L.J.A. Stalpers, C.B.L.M. Majoie, J.C. Reijneveld, W.R. van Furth, D.J. Richel

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1723-1727
Journal	Annals of Oncology
Volume	21
Issue number	8
DOIs	https://doi.org/10.1093/annonc/mdp591
Publication status	Published - 2010

Access to Document

10.1093/annonc/mdp591

Cite this

Verhoeff, J. J. C., Lavini, C., van Linde, M. E., Stalpers, L. J. A., Majoie, C. B. L. M., Reijneveld, J. C., ... Richel, D. J. (2010). Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma. Annals of Oncology, 21(8), 1723-1727. https://doi.org/10.1093/annonc/mdp591

@article{f928f1dd16214bb59f91340e5b58ce41,

title = "Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma",

author = "J.J.C. Verhoeff and C. Lavini and {van Linde}, M.E. and L.J.A. Stalpers and C.B.L.M. Majoie and J.C. Reijneveld and {van Furth}, W.R. and D.J. Richel",

year = "2010",

doi = "10.1093/annonc/mdp591",

language = "Undefined/Unknown",

volume = "21",

pages = "1723--1727",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

AU - Verhoeff, J.J.C.

AU - Lavini, C.

AU - van Linde, M.E.

AU - Stalpers, L.J.A.

AU - Majoie, C.B.L.M.

AU - Reijneveld, J.C.

AU - van Furth, W.R.

AU - Richel, D.J.

PY - 2010

Y1 - 2010

U2 - 10.1093/annonc/mdp591

DO - 10.1093/annonc/mdp591

M3 - Article

C2 - 20064829

VL - 21

SP - 1723

EP - 1727

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -